Type 2 Diabetes Research

As the worldwide incidence of diabetes soars well beyond the quarter-billion mark, Joslin scientists lead in bench-to-bedside research that progresses toward new medications and best treatments.
An Inflammatory Story in Type 2 Diabetes
As salsalate does well in clinical trials for type 2 diabetes, Joslin scientists delve deeper into how the drug works.
Decoding Connections Between Diabetes and Heart Health
Genetic analyses help to unravel the complexities of coronary artery disease.
Exercising Benefits in Diabetes
What Dr. Laurie Goodyear is learning on the molecular level about exercise has practical implications for how we treat people with type 2 diabetes.
Turning Up the Heat on Brown Fat
Joslin researchers unveil secrets of the fat that may make you thinner—and less prone to diabetes.
Guarding the Next Generations from Diabetes
Joslin scientists analyze what can go wrong in diabetic pregnancies, and the nongenetic ways in which risk of diabetes can be handed down.
People at Risk of Diabetes Offer Clues toward Novel Drugs
Joslin researchers pinpoint molecular pathway activated years before people develop type 2 diabetes.
Study Identifies Cells that Give Rise to Brown Fat
In a step toward novel weight-loss therapies, Joslin scientists identify cells in mice that can be triggered to transform into energy-burning brown fat.
- Success in Sight with Diabetes
- An Inflammatory Story in Type 2 Diabetes
- Turning Up the Heat on Brown Fat
- Tracking the Spectrum of Insulin Resistance in Diabetes
- Looking AHEAD with Diabetes
- Studying Interventions for Children with Diabetes
- The Trouble with Tribbles in Diabetes
- Key Protein Links Insulin Action and Insulin Resistance in Diabetes
- Generic Drug for Type 2 Diabetes Passes Next Clinical Hurdle
- Clinical Trial Compares Leading-Edge Treatments for Obesity and Diabetes
- Joslin Study Finds Insulin Regulates Beta Cell Function in Healthy Humans
- Beta cells need key protein to divide and conquer diabetes
Page last updated: March 21, 2013

